Franklin Covey (FC) Financials

Franklin Covey logo
$13.77 -0.77 (-5.28%)
Closing price 03:59 PM Eastern
Extended Trading
$13.79 +0.02 (+0.12%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Franklin Covey

Annual Income Statements for Franklin Covey

This table shows Franklin Covey's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 8/31/2016 8/31/2017 8/31/2018 8/31/2019 8/31/2020 8/31/2021 8/31/2022 8/31/2023 8/31/2024 8/31/2025 8/31/2026
Net Income / (Loss) Attributable to Common Shareholders
277 -7.17 -5.89 -1.02 -9.44 14 17 17 24 2.80 4.78
Consolidated Net Income / (Loss)
7.02 -7.17 -5.89 -1.02 -9.44 14 18 18 23 3.07 4.92
Net Income / (Loss) Continuing Operations
277 -7.17 -5.89 -1.02 -9.44 14 18 18 23 3.07 4.92
Total Pre-Tax Income
12 -11 -5.52 0.59 0.80 6.08 22 26 33 6.07 7.07
Total Operating Income
14 -8.88 -3.37 2.66 3.06 8.10 24 26 33 5.70 7.16
Total Gross Profit
270 123 148 159 145 173 202 213 221 204 196
Total Revenue
400 185 210 225 198 224 263 281 287 267 261
Operating Revenue
400 185 210 225 198 224 263 281 287 267 261
Total Cost of Revenue
130 63 61 66 53 51 61 67 66 63 65
Operating Cost of Revenue
130 63 61 66 53 51 61 67 66 63 65
Total Operating Expenses
-14 132 152 157 142 165 178 187 188 198 189
Selling, General & Admin Expense
114 121 138 141 130 154 168 178 176 181 173
Depreciation Expense
3.68 3.88 5.16 6.36 6.66 6.19 4.90 4.27 3.91 4.07 4.64
Amortization Expense
3.26 3.54 5.37 4.98 4.61 5.01 5.27 4.34 4.25 4.39 2.54
Other Operating Expenses / (Income)
135 - 2.85 4.79 -0.57 - - - 0.00 2.07 1.36
Impairment Charge
- - - - - - 0.00 0.00 0.93 0.00 0.00
Restructuring Charge
0.78 1.48 0.00 0.00 1.64 - 0.00 0.57 3.01 6.72 6.74
Other Special Charges / (Income)
0.00 1.50 - - - - - - 0.00 0.00 0.22
Total Other Income / (Expense), net
-1.94 -2.03 -2.15 -2.06 -2.26 -2.03 -1.61 -0.49 0.00 0.36 -0.10
Interest Expense
2.26 2.41 2.68 2.36 2.32 2.10 1.68 1.58 1.12 0.57 0.31
Interest & Investment Income
0.12 0.22 0.10 0.04 0.06 0.07 0.07 1.09 1.12 0.93 0.21
Income Tax Expense
4.90 -3.74 0.37 1.62 10 -7.55 3.63 8.09 9.64 3.00 2.14
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
- - - - - -0.07 1.25 0.45 -0.22 0.26 0.14
Basic Earnings per Share
$0.47 ($0.52) ($0.43) ($0.07) ($0.68) $0.97 $1.30 $1.30 $1.78 $0.24 $0.43
Weighted Average Basic Shares Outstanding
14.94M 13.82M 13.85M 13.95M 13.89M 14.09M 14.15M 13.64M 13.17M 12.93M 11.55M
Diluted Earnings per Share
$0.47 ($0.52) ($0.43) ($0.07) ($0.68) $0.96 $1.27 $1.24 $1.74 $0.24 $0.42
Weighted Average Diluted Shares Outstanding
15.08M 13.82M 13.85M 13.95M 13.89M 14.14M 14.56M 14.30M 13.47M 13.05M 11.73M
Weighted Average Basic & Diluted Shares Outstanding
14.90M 13.82M 13.85M 13.95M 13.89M 14.29M 13.90M 13.43M 13.18M 12.16M 11.34M

Quarterly Income Statements for Franklin Covey

This table shows Franklin Covey's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026 8/31/2026
Net Income / (Loss) Attributable to Common Shareholders
0.74 5.55 12 0.98 -1.12 -1.26 4.20 -3.50 -1.91 3.08 7.10
Consolidated Net Income / (Loss)
0.87 5.72 12 1.18 -1.08 -1.41 4.37 -3.29 -1.98 3.09 7.11
Net Income / (Loss) Continuing Operations
0.87 5.72 12 1.18 -1.08 -1.41 4.37 -3.29 -1.98 3.09 7.11
Total Pre-Tax Income
1.42 8.36 18 1.59 -1.35 -2.13 7.96 -3.63 -2.06 4.17 8.59
Total Operating Income
1.44 8.34 18 1.48 -1.46 -2.20 7.89 -3.65 -2.00 4.20 8.62
Total Gross Profit
47 56 66 53 46 51 54 48 45 50 52
Total Revenue
61 73 84 69 60 67 71 64 60 68 70
Operating Revenue
61 73 84 69 60 67 71 64 60 68 70
Total Cost of Revenue
14 17 18 16 14 16 17 16 14 18 18
Operating Cost of Revenue
14 17 18 16 14 16 17 16 14 18 18
Total Operating Expenses
45 48 48 51 47 54 46 52 47 46 44
Selling, General & Admin Expense
41 45 45 47 45 46 44 46 43 43 40
Depreciation Expense
0.91 0.99 0.91 0.95 1.02 1.01 1.09 1.10 1.14 1.19 1.22
Amortization Expense
1.07 1.06 1.04 1.10 1.10 1.10 1.10 0.69 0.67 0.61 0.57
Other Operating Expenses / (Income)
- - - 0.00 0.00 0.44 - 0.67 0.46 0.14 0.09
Restructuring Charge
1.73 0.70 - 1.98 0.00 4.74 - 3.44 1.51 0.70 1.09
Total Other Income / (Expense), net
-0.03 0.02 0.06 0.11 0.11 0.08 0.07 0.02 -0.06 -0.03 -0.02
Interest Expense
0.33 0.25 0.20 0.18 0.16 0.14 0.10 0.10 0.09 0.05 0.07
Interest & Investment Income
0.30 0.27 0.27 0.29 0.26 0.21 0.16 0.11 0.03 0.02 0.05
Income Tax Expense
0.54 2.64 6.04 0.41 -0.27 -0.72 3.58 -0.34 -0.08 1.08 1.49
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
0.14 0.18 -0.48 0.20 0.04 -0.15 0.17 0.21 -0.08 0.01 0.01
Basic Earnings per Share
$0.07 $0.43 $0.91 $0.09 ($0.08) ($0.11) $0.34 ($0.27) ($0.17) $0.27 $0.60
Weighted Average Basic Shares Outstanding
13.26M 13.16M 13.17M 13.09M 13.10M 12.89M 12.93M 12.21M 11.42M 11.26M 11.55M
Diluted Earnings per Share
$0.06 $0.43 $0.89 $0.09 ($0.08) ($0.11) $0.34 ($0.27) ($0.17) $0.27 $0.59
Weighted Average Diluted Shares Outstanding
13.48M 13.38M 13.47M 13.27M 13.10M 12.89M 13.05M 12.21M 11.42M 11.45M 11.73M
Weighted Average Basic & Diluted Shares Outstanding
13.27M 13.09M 13.18M 13.20M 12.99M 12.64M 12.16M 11.55M 11.27M 11.29M 11.34M

Annual Cash Flow Statements for Franklin Covey

This table details how cash moves in and out of Franklin Covey's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 8/31/2016 8/31/2017 8/31/2018 8/31/2019 8/31/2020 8/31/2021 8/31/2022 8/31/2023 8/31/2024 8/31/2025 8/31/2026
Net Change in Cash & Equivalents
-5.78 -1.53 1.23 18 -0.56 20 13 -22 10 -17 -18
Net Cash From Operating Activities
33 17 17 30 28 46 52 36 60 29 22
Net Cash From Continuing Operating Activities
33 17 17 30 28 46 52 36 60 29 22
Net Income / (Loss) Continuing Operations
7.02 -7.17 -5.89 -1.02 -9.44 14 18 18 23 3.07 4.92
Consolidated Net Income / (Loss)
7.02 -7.17 -5.89 -1.02 -9.44 14 18 18 23 3.07 4.92
Depreciation Expense
6.94 7.44 11 11 11 11 10 8.61 8.15 8.46 7.18
Amortization Expense
3.87 3.75 5.28 4.95 4.28 4.45 4.27 3.92 3.93 5.05 6.52
Non-Cash Adjustments To Reconcile Net Income
3.17 3.49 2.85 4.79 -0.57 8.62 8.29 13 11 5.81 6.56
Changes in Operating Assets and Liabilities, net
12 9.85 4.10 10 22 8.29 11 -7.09 14 6.60 -3.48
Net Cash From Investing Activities
-6.23 -22 -11 -6.87 -12 -14 -5.33 -14 -11 -17 -12
Net Cash From Continuing Investing Activities
-6.23 -22 -11 -6.87 -12 -14 -5.33 -14 -11 -17 -12
Purchase of Property, Plant & Equipment
-3.99 -7.19 -6.53 -4.15 -4.18 -1.60 -3.18 -4.52 -3.69 -8.25 -5.38
Acquisitions
0.00 -8.02 -1.11 -0.03 0.00 -10 0.00 0.00 -0.75 -1.07 0.00
Other Investing Activities, net
-2.24 -6.47 -3.00 -2.69 -7.68 -2.50 -2.15 -9.04 -6.87 -7.56 -7.01
Net Cash From Financing Activities
-33 3.13 -4.68 -5.93 -17 -11 -33 -44 -39 -29 -28
Net Cash From Continuing Financing Activities
-33 3.13 -4.68 -5.93 -17 -11 -33 -44 -39 -29 -28
Repayment of Debt
-49 -37 -95 -109 -22 -7.60 -8.72 -17 -9.37 -3.95 -13
Repurchase of Common Equity
-44 -5.43 -2.01 -0.01 -14 -2.97 -24 -36 -31 -26 -28
Issuance of Debt
61 44 93 102 20 0.00 0.00 7.50 0.00 0.00 12
Issuance of Common Equity
0.68 0.68 0.81 0.98 1.05 1.07 1.34 1.54 1.47 1.54 1.24
Effect of Exchange Rate Changes
0.32 -0.35 -0.32 -0.10 - - - -0.30 - -0.27 0.11
Cash Interest Paid
2.23 2.31 2.66 2.39 2.28 2.07 1.66 1.50 1.11 0.50 0.25
Cash Income Taxes Paid
3.41 2.56 2.51 1.78 2.06 1.77 3.21 3.31 4.21 7.69 1.24

Quarterly Cash Flow Statements for Franklin Covey

This table details how cash moves in and out of Franklin Covey's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q3 2026 Q4 2026
Period end date 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 5/31/2026 8/31/2026
Net Change in Cash & Equivalents
-4.27 6.95 -4.33 12 4.63 -13 -6.69 -2.01 -14 -1.75 1.32
Net Cash From Operating Activities
17 13 8.17 22 14 -1.37 6.26 9.94 0.10 1.13 4.11
Net Cash From Continuing Operating Activities
17 13 8.17 22 14 -1.37 6.26 9.94 0.10 1.13 4.23
Net Income / (Loss) Continuing Operations
4.85 0.87 5.72 12 1.18 -1.08 -1.41 4.37 -3.29 3.09 7.11
Consolidated Net Income / (Loss)
4.85 0.87 5.72 12 1.18 -1.08 -1.41 4.37 -3.29 3.09 7.11
Depreciation Expense
2.16 1.98 2.05 1.96 2.05 2.12 2.11 2.19 1.79 1.80 1.79
Amortization Expense
0.89 1.01 1.03 1.00 1.20 1.26 1.20 1.39 1.44 1.75 1.80
Non-Cash Adjustments To Reconcile Net Income
2.90 2.30 2.83 3.05 2.17 1.35 2.22 0.08 1.43 1.50 1.31
Changes in Operating Assets and Liabilities, net
6.64 6.61 -3.46 3.92 7.55 -5.02 2.14 1.92 -1.26 -7.01 -7.78
Net Cash From Investing Activities
-3.74 -1.75 -2.33 -3.50 -2.75 -2.22 -3.49 -8.42 -3.75 -2.15 -3.38
Net Cash From Continuing Investing Activities
-3.74 -1.75 -2.33 -3.50 -2.75 -2.22 -3.49 -8.42 -3.75 -2.15 -3.38
Purchase of Property, Plant & Equipment
-1.07 -0.64 -0.90 -1.08 -1.00 -1.27 -1.78 -4.20 -1.73 -1.16 -1.46
Other Investing Activities, net
-2.67 -1.10 -1.43 -1.67 -1.43 -0.95 -1.72 -3.47 -2.02 -0.99 -1.93
Net Cash From Financing Activities
-18 -3.90 -10 -6.69 -6.58 -9.31 -9.72 -3.17 -10 -0.52 0.36
Net Cash From Continuing Financing Activities
-18 -3.90 -10 -6.69 -6.58 -9.31 -9.72 -3.17 -10 -0.52 0.36
Repurchase of Common Equity
-16 -2.11 -7.43 -4.91 -5.95 -8.70 -8.33 -3.38 -11 -0.01 -0.01
Issuance of Common Equity
0.36 0.33 0.39 0.39 0.32 0.36 0.43 0.44 0.29 0.32 0.37
Effect of Exchange Rate Changes
0.09 -0.18 -0.16 0.40 - 0.00 0.27 -0.36 -0.14 -0.20 0.23
Cash Interest Paid
0.34 0.28 0.32 0.18 0.14 0.12 0.16 0.07 0.07 0.06 0.05
Cash Income Taxes Paid
0.82 0.82 1.32 1.24 0.75 5.28 1.02 0.64 0.35 0.15 0.81

Annual Balance Sheets for Franklin Covey

This table presents Franklin Covey's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 8/31/2016 8/31/2017 8/31/2018 8/31/2019 8/31/2020 8/31/2021 8/31/2022 8/31/2023 8/31/2024 8/31/2025 8/31/2026
Total Assets
191 211 214 225 205 250 259 246 262 243 218
Total Current Assets
90 92 100 119 102 137 156 145 160 129 112
Cash & Equivalents
10 8.92 10 28 27 47 61 38 49 32 13
Accounts Receivable
68 66 72 73 56 71 73 82 86 68 68
Inventories, net
5.04 3.35 3.16 3.48 2.97 2.50 3.53 4.21 4.00 5.17 5.79
Prepaid Expenses
2.95 3.57 3.86 3.91 3.65 3.25 4.71 4.40 5.11 5.11 5.09
Other Current Assets
3.40 9.39 11 11 12 13 15 16 16 19 20
Plant, Property, & Equipment, net
16 20 21 19 16 12 9.80 10 8.74 14 12
Total Noncurrent Assets
85 99 92 87 88 101 93 91 93 99 93
Goodwill
20 24 24 24 24 31 31 31 31 31 31
Intangible Assets
50 57 52 48 47 50 45 41 38 35 31
Noncurrent Deferred & Refundable Income Taxes
- 1.65 3.22 5.05 1.09 4.95 4.69 1.66 0.87 0.23 1.14
Other Noncurrent Operating Assets
14 16 13 10 16 15 13 17 23 33 30
Total Liabilities & Shareholders' Equity
191 211 214 225 205 250 259 246 262 243 218
Total Liabilities
97 126 133 143 146 170 176 167 178 176 167
Total Current Liabilities
54 81 95 104 103 137 154 152 162 157 151
Short-Term Debt
5.41 8.12 12 7.34 5.00 5.84 5.84 5.84 0.84 0.82 0.00
Accounts Payable
10 9.12 9.79 9.67 5.62 6.95 11 6.50 7.86 8.78 6.05
Accrued Expenses
17 23 21 24 23 35 34 28 32 25 23
Customer Deposits
- - - - - - - 12 17 16 8.95
Current Deferred Revenue
21 41 52 56 59 75 86 95 101 107 113
Other Current Nonoperating Liabilities
- - - - - - - - - 0.00 1.00
Total Noncurrent Liabilities
43 45 39 39 43 33 23 16 16 19 16
Noncurrent Deferred & Payable Income Tax Liabilities
6.67 1.03 0.21 0.18 5.30 0.38 0.20 2.04 3.13 3.99 4.71
Other Noncurrent Operating Liabilities
3.17 5.74 5.50 7.53 23 20 15 12 12 15 11
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
94 85 81 82 59 80 83 79 83 67 51
Total Preferred & Common Equity
94 85 81 82 59 80 83 79 83 67 51
Total Common Equity
94 85 81 82 59 80 83 79 83 67 51
Common Stock
213 214 213 217 213 216 222 234 233 232 231
Retained Earnings
77 69 64 59 50 64 82 100 123 126 131
Treasury Stock
-197 -199 -196 -195 -204 -201 -220 -254 -272 -290 -310
Accumulated Other Comprehensive Income / (Loss)
1.22 0.67 0.34 0.27 0.64 0.71 -0.54 -0.99 -0.77 -1.03 -1.18

Quarterly Balance Sheets for Franklin Covey

This table presents Franklin Covey's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 2/28/2023 5/31/2023 11/30/2023 2/29/2024 5/31/2024 11/30/2024 2/28/2025 5/31/2025 11/30/2025 2/28/2026 5/31/2026
Total Assets
234 218 219 222 221 240 221 218 221 206 198
Total Current Assets
131 117 117 122 120 139 121 111 109 95 92
Cash & Equivalents
55 39 34 41 37 53 40 34 18 14 12
Accounts Receivable
54 55 60 57 60 61 53 50 59 50 50
Inventories, net
3.47 4.57 4.12 4.20 4.64 3.83 4.09 4.06 5.30 5.34 5.80
Prepaid Expenses
19 17 19 20 18 20 23 23 27 26 24
Plant, Property, & Equipment, net
9.85 9.70 9.52 8.71 8.63 8.73 9.55 9.87 14 13 13
Total Noncurrent Assets
93 91 92 91 92 92 91 97 99 98 94
Goodwill
31 31 31 31 31 31 31 31 31 31 31
Intangible Assets
43 42 39 38 39 37 36 36 34 32 32
Noncurrent Deferred & Refundable Income Taxes
3.56 2.27 1.68 1.66 1.64 0.83 0.82 0.85 0.23 0.24 0.24
Other Noncurrent Operating Assets
16 16 20 20 21 23 23 30 33 34 30
Total Liabilities & Shareholders' Equity
234 218 219 222 221 240 221 218 221 206 198
Total Liabilities
143 143 148 151 149 159 149 153 167 168 155
Total Current Liabilities
125 128 135 138 137 144 134 132 149 152 140
Short-Term Debt
5.84 5.84 4.59 3.34 2.09 0.84 0.84 0.82 0.83 0.84 0.00
Accounts Payable
8.49 7.10 5.67 7.73 6.19 5.96 6.80 6.23 5.53 6.61 6.42
Accrued Expenses
19 24 21 19 22 24 17 21 21 22 21
Customer Deposits
- - - - 22 22 20 20 25 25 20
Current Deferred Revenue
74 70 83 82 80 89 88 83 96 98 93
Other Current Liabilities
18 21 20 26 3.81 2.17 1.20 0.22 0.00 0.00 0.00
Total Noncurrent Liabilities
18 15 14 13 12 16 15 20 19 16 15
Long-Term Debt
4.82 2.76 1.56 1.58 0.76 0.79 0.80 0.00 0.00 0.00 0.00
Noncurrent Deferred & Payable Income Tax Liabilities
0.20 0.20 1.01 1.06 1.85 2.91 2.98 3.15 5.10 4.50 4.02
Other Noncurrent Operating Liabilities
13 12 11 10 9.61 12 11 17 13 12 11
Total Equity & Noncontrolling Interests
91 75 71 71 72 81 73 66 54 38 43
Total Preferred & Common Equity
91 75 71 71 72 81 73 66 54 38 43
Total Common Equity
91 75 71 71 72 81 73 66 54 38 43
Common Stock
227 230 226 227 230 229 229 232 231 231 231
Retained Earnings
88 93 105 106 111 124 123 122 123 121 124
Treasury Stock
-224 -248 -259 -261 -268 -271 -279 -287 -298 -313 -311
Accumulated Other Comprehensive Income / (Loss)
-0.53 -0.67 -0.94 -1.08 -1.25 -0.97 -1.01 -0.86 -1.24 -1.16 -1.17

Annual Metrics And Ratios for Franklin Covey

This table displays calculated financial ratios and metrics derived from Franklin Covey's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 8/31/2016 8/31/2017 8/31/2018 8/31/2019 8/31/2020 8/31/2021 8/31/2022 8/31/2023 8/31/2024 8/31/2025 8/31/2026
DEI Shares Outstanding
14,176,603.00 13,859,482.00 13,907,731.00 13,974,222.00 13,877,984.00 14,156,827.00 - - - 12,641,822.00 11,293,873.00
DEI Adjusted Shares Outstanding
14,176,603.00 13,859,482.00 13,907,731.00 13,974,222.00 13,877,984.00 14,156,827.00 - - - 12,641,822.00 11,293,873.00
DEI Earnings Per Adjusted Shares Outstanding
19.56 -0.52 -0.42 -0.07 -0.68 0.97 - - - 0.22 0.42
Growth Metrics
- - - - - - - - - - -
Revenue Growth
90.58% -53.70% 13.23% 7.44% -11.94% 12.96% 17.25% 6.73% 2.39% -7.02% -2.10%
EBITDA Growth
-20.13% -90.09% 421.79% 49.54% -3.21% 27.61% 60.50% 2.05% 16.03% -57.43% 8.61%
EBIT Growth
-26.65% -162.05% 66.21% 198.81% 4.98% 164.91% 192.24% 11.35% 25.34% -82.74% 25.60%
NOPAT Growth
-34.57% -176.20% 62.09% -94.72% -690.04% 150.12% 8.85% -8.37% 29.14% -87.67% 73.04%
Net Income Growth
-36.88% -202.22% 17.92% 82.62% -822.29% 244.39% 35.29% -3.52% 31.61% -86.89% 60.46%
EPS Growth
-28.79% -210.64% 17.31% 83.72% -871.43% 241.18% 32.29% -2.36% 40.32% -86.21% 75.00%
Operating Cash Flow Growth
24.72% -46.86% -2.86% 80.61% -9.49% 67.53% 13.16% -31.61% 68.61% -51.91% -25.50%
Free Cash Flow Firm Growth
4.13% -131.57% 167.46% 284.83% -73.22% 306.00% 85.32% -83.93% 513.28% -91.65% -33.58%
Invested Capital Growth
-9.92% 0.49% -5.67% -19.27% -43.93% -2.03% -30.93% 35.01% -24.51% -0.13% 8.45%
Revenue Q/Q Growth
97.42% -52.57% 2.59% 0.15% -7.53% 9.77% 3.90% -0.30% 2.20% -4.60% 0.00%
EBITDA Q/Q Growth
0.15% -67.84% 10.69% 5.32% -20.00% 1.67% 11.83% 3.85% 18.98% -32.90% 0.00%
EBIT Q/Q Growth
3.47% -217.70% 15.58% 90.77% -61.99% 7.60% 22.52% 7.79% 28.65% -63.77% 0.00%
NOPAT Q/Q Growth
0.94% -223.38% 3.61% -529.22% -471.95% 2.54% 23.21% 6.13% 27.25% -72.31% 0.00%
Net Income Q/Q Growth
0.80% -74.67% -95.84% 80.02% -107.82% 6.46% 25.72% 7.46% 28.17% -71.20% 0.00%
EPS Q/Q Growth
14.63% -52.94% -104.76% 81.08% -106.06% 5.49% 23.30% 10.71% 30.83% -69.62% 0.00%
Operating Cash Flow Q/Q Growth
0.07% -22.71% 18.00% 13.23% -9.74% 16.30% -4.75% -7.57% 25.08% -29.17% -21.26%
Free Cash Flow Firm Q/Q Growth
-1.01% -227.90% 180.91% -27.25% -69.11% 7.96% -31.71% -45.46% 47.95% -81.87% 0.00%
Invested Capital Q/Q Growth
-0.34% 6.46% -2.33% -1.88% -28.74% -30.10% -4.85% 9.18% -6.12% 10.24% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
67.56% 66.21% 70.70% 70.69% 73.25% 77.13% 76.82% 76.10% 76.97% 76.22% 74.98%
EBITDA Margin
6.22% 1.33% 6.13% 8.53% 9.38% 10.59% 14.50% 13.86% 15.71% 7.19% 7.98%
Operating Margin
3.46% -4.79% -1.60% 1.18% 1.54% 3.61% 9.01% 9.40% 11.50% 2.14% 2.74%
EBIT Margin
3.51% -4.71% -1.41% 1.29% 1.54% 3.61% 9.01% 9.40% 11.50% 2.14% 2.74%
Profit (Net Income) Margin
1.75% -3.87% -2.81% -0.45% -4.75% 6.08% 7.01% 6.34% 8.15% 1.15% 1.88%
Tax Burden Percent
58.90% 65.74% 106.65% -172.80% -1,185.30% 224.25% 83.53% 68.73% 70.82% 50.57% 69.67%
Interest Burden Percent
84.72% 125.05% 187.25% 20.32% 26.03% 74.99% 93.20% 98.13% 100.01% 106.36% 98.63%
Effective Tax Rate
41.10% 0.00% 0.00% 272.80% 1,285.30% -124.25% 16.47% 31.27% 29.18% 49.43% 30.33%
Return on Invested Capital (ROIC)
6.34% -5.09% -1.98% -4.39% -49.78% 35.08% 45.64% 43.56% 55.79% 8.00% 13.29%
ROIC Less NNEP Spread (ROIC-NNEP)
0.34% -8.00% -11.72% 10.99% 1,243.27% 60.50% 49.18% 44.42% 55.79% 7.53% 13.61%
Return on Net Nonoperating Assets (RNNOA)
0.06% -2.94% -5.13% 3.13% 36.45% -15.52% -22.98% -21.53% -26.87% -3.91% -4.96%
Return on Equity (ROE)
6.40% -8.02% -7.11% -1.26% -13.34% 19.56% 22.66% 22.02% 28.93% 4.09% 8.32%
Cash Return on Invested Capital (CROIC)
16.78% -5.57% 3.86% 16.94% 6.50% 37.13% 82.24% 13.76% 83.72% 8.13% 5.18%
Operating Return on Assets (OROA)
7.18% -4.34% -1.39% 1.33% 1.42% 3.56% 9.31% 10.44% 13.02% 2.26% 3.11%
Return on Assets (ROA)
3.58% -3.57% -2.77% -0.47% -4.38% 5.99% 7.24% 7.04% 9.22% 1.22% 2.14%
Return on Common Equity (ROCE)
6.40% -8.02% -7.11% -1.26% -13.34% 19.56% 22.66% 22.02% 28.93% 4.09% 8.32%
Return on Equity Simple (ROE_SIMPLE)
7.49% -8.43% -7.31% -1.25% -15.87% 17.06% 22.25% 22.61% 28.15% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
8.16 -6.22 -2.36 -4.59 -36 18 20 18 23 2.88 4.99
NOPAT Margin
2.04% -3.36% -1.12% -2.04% -18.26% 8.10% 7.52% 6.46% 8.15% 1.08% 1.91%
Net Nonoperating Expense Percent (NNEP)
6.00% 2.91% 9.74% -15.38% -1,293.06% -25.42% -3.54% -0.86% 0.01% 0.47% -0.32%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 4.26% 9.72%
Cost of Revenue to Revenue
32.44% 33.79% 29.30% 29.31% 26.75% 22.87% 23.18% 23.90% 23.03% 23.78% 25.02%
SG&A Expenses to Revenue
28.39% 65.39% 65.92% 62.36% 65.50% 68.52% 63.94% 63.44% 61.25% 68.40% 66.31%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
-3.46% 71.01% 72.30% 69.52% 71.71% 73.52% 67.81% 66.71% 65.46% 74.09% 72.24%
Earnings before Interest and Taxes (EBIT)
14 -8.72 -2.95 2.91 3.06 8.10 24 26 33 5.70 7.16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
25 2.46 13 19 19 24 38 39 45 19 21
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.46 3.06 4.42 6.27 4.61 7.71 7.96 7.16 6.34 3.70 4.47
Price to Tangible Book Value (P/TBV)
9.75 73.38 81.92 50.88 0.00 0.00 97.51 81.39 37.26 216.91 0.00
Price to Revenue (P/Rev)
0.58 1.41 1.70 2.28 1.38 2.75 2.51 2.01 1.84 0.93 0.88
Price to Earnings (P/E)
0.83 0.00 0.00 0.00 0.00 44.95 38.37 32.50 22.32 88.19 48.09
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
120.46% 0.00% 0.00% 0.00% 0.00% 2.22% 2.61% 3.08% 4.48% 1.13% 2.08%
Enterprise Value to Invested Capital (EV/IC)
2.12 2.43 3.38 5.63 5.10 11.45 17.28 11.14 13.31 6.01 5.54
Enterprise Value to Revenue (EV/Rev)
0.65 1.61 1.86 2.33 1.34 2.62 2.33 1.90 1.67 0.81 0.83
Enterprise Value to EBITDA (EV/EBITDA)
10.39 120.95 30.42 27.33 14.34 24.71 16.05 13.69 10.64 11.26 10.38
Enterprise Value to EBIT (EV/EBIT)
18.38 0.00 0.00 180.36 87.25 72.43 25.84 20.20 14.53 37.94 30.23
Enterprise Value to NOPAT (EV/NOPAT)
31.68 0.00 0.00 0.00 0.00 32.30 30.94 29.39 20.52 75.02 43.38
Enterprise Value to Operating Cash Flow (EV/OCF)
7.91 17.17 23.20 17.25 9.68 12.71 11.71 14.90 7.97 7.47 10.03
Enterprise Value to Free Cash Flow (EV/FCFF)
11.98 0.00 85.10 29.71 56.34 30.52 17.17 93.02 13.67 73.85 111.26
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.41 0.55 0.56 0.48 0.34 0.24 0.16 0.09 0.02 0.01 0.00
Long-Term Debt to Equity
0.35 0.45 0.41 0.39 0.25 0.16 0.09 0.02 0.01 0.00 0.00
Financial Leverage
0.17 0.37 0.44 0.29 0.03 -0.26 -0.47 -0.48 -0.48 -0.52 -0.36
Leverage Ratio
1.79 2.25 2.56 2.70 3.04 3.27 3.13 3.13 3.14 3.36 3.90
Compound Leverage Factor
1.51 2.81 4.80 0.55 0.79 2.45 2.92 3.07 3.14 3.58 3.85
Debt to Total Capital
29.21% 35.29% 35.97% 32.22% 25.17% 19.06% 13.66% 8.57% 1.90% 1.22% 0.00%
Short-Term Debt to Total Capital
4.09% 6.18% 9.87% 6.06% 6.29% 5.91% 6.08% 6.78% 0.99% 1.22% 0.00%
Long-Term Debt to Total Capital
25.12% 29.11% 26.10% 26.16% 18.88% 13.15% 7.58% 1.78% 0.91% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
70.79% 64.71% 64.03% 67.78% 74.83% 80.94% 86.34% 91.43% 98.10% 98.79% 100.00%
Debt to EBITDA
1.56 18.82 3.52 2.03 1.07 0.79 0.34 0.19 0.04 0.04 0.00
Net Debt to EBITDA
1.13 15.20 2.73 0.59 -0.38 -1.20 -1.24 -0.79 -1.04 -1.61 0.00
Long-Term Debt to EBITDA
1.34 15.53 2.55 1.65 0.81 0.55 0.19 0.04 0.02 0.00 0.00
Debt to NOPAT
4.74 -7.46 -19.19 -8.50 -0.55 1.04 0.66 0.41 0.07 0.29 0.00
Net Debt to NOPAT
3.46 -6.03 -14.89 -2.46 0.20 -1.57 -2.40 -1.70 -2.01 -10.70 0.00
Long-Term Debt to NOPAT
4.08 -6.16 -13.93 -6.90 -0.41 0.71 0.37 0.08 0.03 0.00 0.00
Altman Z-Score
4.55 2.51 2.98 3.66 2.48 3.54 4.01 4.05 3.94 2.61 2.76
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.66 1.14 1.06 1.15 0.99 1.00 1.01 0.96 0.99 0.82 0.74
Quick Ratio
1.45 0.93 0.87 0.97 0.81 0.86 0.87 0.79 0.83 0.64 0.54
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
22 -6.81 4.60 18 4.74 19 36 5.73 35 2.93 1.95
Operating Cash Flow to CapEx
818.06% 241.51% 258.29% 733.25% 658.93% 2,882.46% 1,644.76% 791.54% 1,631.21% 351.11% 401.62%
Free Cash Flow to Firm to Interest Expense
9.54 -2.83 1.72 7.50 2.04 9.16 21.27 3.62 31.38 5.19 6.28
Operating Cash Flow to Interest Expense
14.43 7.21 6.30 12.91 11.89 22.00 31.20 22.58 53.85 51.29 69.64
Operating Cash Flow Less CapEx to Interest Expense
12.67 4.22 3.86 11.15 10.09 21.24 29.30 19.72 50.55 36.68 52.30
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
2.04 0.92 0.99 1.03 0.92 0.99 1.03 1.11 1.13 1.06 1.13
Accounts Receivable Turnover
5.91 2.76 3.03 3.11 3.06 3.53 3.67 3.63 3.42 3.46 3.84
Inventory Turnover
28.87 14.91 18.88 19.89 16.45 18.74 20.23 17.32 16.11 13.85 11.94
Fixed Asset Turnover
25.34 10.35 10.20 11.27 11.57 16.45 24.65 28.28 30.60 23.16 19.52
Accounts Payable Turnover
13.90 6.42 6.50 6.79 6.94 8.16 6.84 7.72 9.21 7.63 8.82
Days Sales Outstanding (DSO)
61.80 132.24 120.29 117.54 119.21 103.46 99.46 100.51 106.70 105.52 95.06
Days Inventory Outstanding (DIO)
12.64 24.48 19.34 18.35 22.19 19.47 18.04 21.07 22.66 26.35 30.57
Days Payable Outstanding (DPO)
26.27 56.84 56.14 53.77 52.56 44.75 53.35 47.28 39.62 47.83 41.37
Cash Conversion Cycle (CCC)
48.18 99.87 83.49 82.12 88.84 78.19 64.15 74.31 89.74 84.04 84.26
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
122 123 116 93 52 51 35 48 36 36 39
Invested Capital Turnover
3.11 1.52 1.76 2.16 2.73 4.33 6.07 6.74 6.85 7.41 6.96
Increase / (Decrease) in Invested Capital
-13 0.60 -6.95 -22 -41 -1.06 -16 12 -12 -0.05 3.05
Enterprise Value (EV)
258 298 391 525 267 587 612 533 480 216 217
Market Capitalization
230 261 356 514 274 615 659 563 527 247 230
Book Value per Share
$6.61 $6.14 $5.79 $5.87 $4.28 $5.64 $5.98 $5.96 $6.35 $5.29 $4.55
Tangible Book Value per Share
$1.67 $0.26 $0.31 $0.72 ($0.86) ($0.10) $0.49 $0.52 $1.08 $0.09 ($0.96)
Total Capital
132 131 126 121 79 99 96 86 85 68 51
Total Debt
39 46 45 39 20 19 13 7.37 1.61 0.82 0.00
Total Long-Term Debt
33 38 33 32 15 13 7.27 1.54 0.78 0.00 0.00
Net Debt
28 37 35 11 -7.14 -29 -47 -31 -47 -31 -13
Capital Expenditures (CapEx)
3.99 7.19 6.53 4.15 4.18 1.60 3.18 4.52 3.69 8.25 5.38
Debt-free, Cash-free Net Working Capital (DFCFNWC)
31 10 7.57 -4.57 -23 -41 -53 -39 -50 -59 -52
Debt-free Net Working Capital (DFNWC)
41 19 18 23 4.14 6.00 7.92 -0.80 -1.37 -27 -39
Net Working Capital (NWC)
36 11 5.32 16 -0.86 0.17 2.09 -6.63 -2.20 -28 -39
Net Nonoperating Expense (NNE)
1.14 0.96 3.53 -3.56 -27 4.54 1.34 0.34 -0.00 -0.18 0.07
Net Nonoperating Obligations (NNO)
28 37 35 11 -7.14 -29 -47 -31 -47 -31 -12
Total Depreciation and Amortization (D&A)
11 11 16 16 16 16 14 13 12 14 14
Debt-free, Cash-free Net Working Capital to Revenue
7.66% 5.62% 3.61% -2.03% -11.59% -18.47% -20.01% -13.91% -17.42% -21.98% -19.95%
Debt-free Net Working Capital to Revenue
10.27% 10.43% 8.45% 10.26% 2.08% 2.68% 3.01% -0.28% -0.48% -10.11% -14.86%
Net Working Capital to Revenue
8.92% 6.05% 2.54% 7.01% -0.44% 0.08% 0.79% -2.36% -0.77% -10.42% -14.86%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.47 ($0.52) ($0.43) ($0.07) ($0.68) $0.97 $1.30 $1.30 $1.78 $0.24 $0.43
Adjusted Weighted Average Basic Shares Outstanding
14.94M 13.82M 13.85M 13.98M 14.03M 14.09M 14.15M 13.64M 13.17M 12.93M 11.55M
Adjusted Diluted Earnings per Share
$0.47 ($0.52) ($0.43) ($0.07) ($0.68) $0.96 $1.27 $1.24 $1.74 $0.24 $0.42
Adjusted Weighted Average Diluted Shares Outstanding
15.08M 13.82M 13.85M 13.98M 14.03M 14.14M 14.56M 14.30M 13.47M 13.05M 11.73M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($0.52) ($0.43) ($0.07) ($0.68) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
13.79M 13.70M 13.92M 13.95M 13.89M 14.29M 13.90M 13.43M 13.18M 12.16M 11.34M
Normalized Net Operating Profit after Tax (NOPAT)
8.61 -4.13 -2.36 1.86 3.29 5.67 20 19 26 6.28 9.84
Normalized NOPAT Margin
2.15% -2.23% -1.12% 0.82% 1.66% 2.53% 7.52% 6.60% 9.12% 2.35% 3.76%
Pre Tax Income Margin
2.98% -5.89% -2.63% 0.26% 0.40% 2.71% 8.39% 9.22% 11.50% 2.27% 2.70%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
6.21 -3.62 -1.10 1.24 1.32 3.86 14.13 16.65 29.53 10.10 23.11
NOPAT to Interest Expense
3.60 -2.58 -0.88 -1.95 -15.64 8.65 11.81 11.45 20.91 5.11 16.10
EBIT Less CapEx to Interest Expense
4.45 -6.61 -3.54 -0.53 -0.49 3.10 12.24 13.80 26.23 -4.51 5.77
NOPAT Less CapEx to Interest Expense
1.84 -5.57 -3.32 -3.71 -17.44 7.89 9.91 8.59 17.61 -9.50 -1.24
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
621.24% -75.73% -34.08% -1.17% -148.08% 21.81% 129.41% 199.96% 131.39% 859.65% 571.40%

Quarterly Metrics And Ratios for Franklin Covey

This table displays calculated financial ratios and metrics derived from Franklin Covey's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026 8/31/2026
DEI Shares Outstanding
- - - - - 12,987,725.00 12,641,822.00 12,155,832.00 11,552,552.00 11,272,444.00 11,293,873.00
DEI Adjusted Shares Outstanding
- - - - - 12,987,725.00 12,641,822.00 12,155,832.00 11,552,552.00 11,272,444.00 11,293,873.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - -0.10 0.33 -0.29 -0.17 0.27 0.63
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.68% 2.70% 7.91% 1.00% -2.81% -8.52% -15.31% -7.30% 0.06% 1.02% -1.81%
EBITDA Growth
-24.54% 19.64% 52.61% -43.71% -56.69% -90.29% -45.11% -109.09% -109.72% 598.02% 6.51%
EBIT Growth
-49.01% 26.95% 69.63% -72.32% -200.90% -126.41% -56.01% -347.53% -37.39% 290.47% 9.27%
NOPAT Growth
-49.63% 25.22% 72.85% -77.60% -214.35% -127.02% -63.62% -332.83% -37.39% 301.49% 64.46%
Net Income Growth
-49.74% 25.38% 75.51% -75.65% -223.11% -124.63% -63.43% -378.49% -84.20% 318.95% 62.60%
EPS Growth
-50.00% 34.38% 85.42% -75.00% -233.33% -125.58% -61.80% -400.00% -112.50% 345.45% 73.53%
Operating Cash Flow Growth
55.95% -44.55% 123.39% -18.88% -110.72% -23.37% -54.56% -99.31% 0.00% -82.04% -58.63%
Free Cash Flow Firm Growth
451.47% 647.90% 529.48% 166.12% -99.66% -61.94% -81.46% -173.61% 16,090.34% 14.89% -6.77%
Invested Capital Growth
-25.72% -12.20% -24.51% -32.11% -3.05% -14.95% -0.13% 28.78% -25.48% -5.27% 8.45%
Revenue Q/Q Growth
-10.33% 19.62% 14.65% -17.88% -13.71% 12.60% 6.15% -10.11% 0.00% 13.68% 3.17%
EBITDA Q/Q Growth
-47.02% 157.36% 82.72% -77.40% -59.24% -42.28% 932.52% -103.74% 0.00% 4,199.47% 57.55%
EBIT Q/Q Growth
-72.94% 478.57% 114.89% -91.77% -198.64% -51.41% 458.01% -146.29% 0.00% 309.91% 105.39%
NOPAT Q/Q Growth
-81.82% 540.71% 108.78% -90.79% -192.79% -51.41% 381.09% -158.96% 0.00% 322.06% 129.43%
Net Income Q/Q Growth
-81.98% 554.58% 108.98% -90.12% -191.11% -30.95% 410.29% -175.23% 0.00% 255.65% 130.44%
EPS Q/Q Growth
-83.33% 616.67% 106.98% -89.89% -188.89% -37.50% 409.09% -179.41% 0.00% 258.82% 118.52%
Operating Cash Flow Q/Q Growth
-26.75% -36.02% 167.61% -35.33% -109.68% 557.49% 58.68% -99.01% 0.00% 0.00% 265.42%
Free Cash Flow Firm Q/Q Growth
132.87% -14.71% 113.84% -37.34% -99.70% 9,349.21% 4.18% -348.75% 0.00% -32.94% -15.47%
Invested Capital Q/Q Growth
-18.39% 10.33% -6.12% -19.69% 16.55% -3.21% 10.24% 3.56% 0.00% 23.03% 26.21%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
76.38% 76.60% 78.14% 76.30% 76.74% 76.46% 75.50% 75.53% 75.90% 73.88% 74.75%
EBITDA Margin
7.24% 15.57% 24.82% 6.83% 3.23% 1.65% 16.09% -0.67% -0.32% 11.43% 17.45%
Operating Margin
2.35% 11.37% 21.31% 2.14% -2.44% -3.28% 11.07% -5.70% -3.35% 6.19% 12.32%
EBIT Margin
2.35% 11.37% 21.31% 2.14% -2.44% -3.28% 11.07% -5.70% -3.35% 6.19% 12.32%
Profit (Net Income) Margin
1.42% 7.80% 14.21% 1.71% -1.81% -2.10% 6.14% -5.14% -3.32% 4.55% 10.16%
Tax Burden Percent
61.77% 68.40% 66.46% 74.42% 79.82% 66.24% 54.96% 90.56% 96.12% 74.05% 82.72%
Interest Burden Percent
98.13% 100.25% 100.35% 107.59% 92.65% 96.55% 100.86% 99.48% 103.15% 99.29% 99.72%
Effective Tax Rate
38.23% 31.60% 33.54% 25.58% 0.00% 0.00% 45.04% 0.00% 0.00% 25.95% 17.28%
Return on Invested Capital (ROIC)
9.92% 53.18% 97.00% 12.77% -14.25% -18.09% 45.06% -31.54% 0.00% 0.00% 70.94%
ROIC Less NNEP Spread (ROIC-NNEP)
9.96% 53.13% 96.89% 12.56% -14.10% -18.49% 44.96% -29.40% 0.00% 0.00% 71.03%
Return on Net Nonoperating Assets (RNNOA)
-4.94% -23.35% -46.66% -6.60% 7.35% 8.94% -23.35% 14.93% 0.00% 0.00% -25.92%
Return on Equity (ROE)
4.98% 29.83% 50.34% 6.16% -6.90% -9.15% 21.71% -16.62% 0.00% 0.00% 45.02%
Cash Return on Invested Capital (CROIC)
71.71% 57.73% 83.72% 93.01% 54.35% 45.45% 8.13% -28.05% 0.00% 0.00% 5.18%
Operating Return on Assets (OROA)
2.88% 14.57% 24.13% 2.68% -3.15% -4.18% 11.72% -6.48% 0.00% 0.00% 13.97%
Return on Assets (ROA)
1.74% 9.99% 16.09% 2.15% -2.33% -2.68% 6.50% -5.84% 0.00% 0.00% 11.52%
Return on Common Equity (ROCE)
4.98% 29.83% 50.34% 6.16% -6.90% -9.15% 21.71% -16.62% 0.00% 0.00% 45.02%
Return on Equity Simple (ROE_SIMPLE)
24.14% 25.30% 0.00% 24.47% 24.52% 16.24% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
0.89 5.71 12 1.10 -1.02 -1.54 4.33 -2.56 -1.40 3.11 7.13
NOPAT Margin
1.45% 7.78% 14.16% 1.59% -1.71% -2.30% 6.08% -3.99% -2.35% 4.58% 10.19%
Net Nonoperating Expense Percent (NNEP)
-0.04% 0.04% 0.11% 0.21% -0.15% 0.40% 0.10% -2.15% -2.26% -0.10% -0.09%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.33% -1.37% -2.32% 6.40% -4.66% -3.60% 7.24% 13.88%
Cost of Revenue to Revenue
23.62% 23.40% 21.86% 23.70% 23.26% 23.54% 24.50% 24.47% 24.10% 26.12% 25.25%
SG&A Expenses to Revenue
66.47% 61.48% 53.82% 68.33% 75.63% 69.54% 61.36% 72.01% 72.92% 63.80% 57.88%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
74.03% 65.23% 56.83% 74.16% 79.18% 79.74% 64.43% 81.23% 79.25% 67.69% 62.43%
Earnings before Interest and Taxes (EBIT)
1.44 8.34 18 1.48 -1.46 -2.20 7.89 -3.65 -2.00 4.20 8.62
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
4.44 11 21 4.72 1.92 1.11 11 -0.43 -0.19 7.75 12
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.16 6.80 6.34 5.95 5.82 4.63 3.70 3.54 3.95 6.23 4.47
Price to Tangible Book Value (P/TBV)
410.41 229.90 37.26 39.11 80.55 0.00 216.91 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.82 1.75 1.84 1.67 1.47 1.08 0.93 0.73 0.00 0.00 0.88
Price to Earnings (P/E)
30.65 27.77 22.32 24.35 23.65 27.51 88.19 0.00 0.00 0.00 48.09
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
3.26% 3.60% 4.48% 4.11% 4.23% 3.64% 1.13% 0.00% 0.00% 0.00% 2.08%
Enterprise Value to Invested Capital (EV/IC)
13.53 11.89 13.31 14.77 11.35 8.28 6.01 4.67 5.46 8.25 5.54
Enterprise Value to Revenue (EV/Rev)
1.69 1.63 1.67 1.49 1.34 0.97 0.81 0.67 0.00 0.00 0.83
Enterprise Value to EBITDA (EV/EBITDA)
13.07 12.05 10.64 10.32 9.84 9.46 11.26 12.40 0.00 0.00 10.38
Enterprise Value to EBIT (EV/EBIT)
19.71 17.80 14.53 14.66 14.58 17.20 37.94 301.72 0.00 0.00 30.23
Enterprise Value to NOPAT (EV/NOPAT)
27.33 24.86 20.52 21.81 21.80 26.00 75.02 0.00 0.00 0.00 43.38
Enterprise Value to Operating Cash Flow (EV/OCF)
8.61 9.49 7.97 7.51 8.95 6.62 7.47 11.68 4.23 9.32 10.03
Enterprise Value to Free Cash Flow (EV/FCFF)
16.08 19.26 13.67 12.84 20.56 16.75 73.85 0.00 0.00 0.00 111.26
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.07 0.04 0.02 0.02 0.02 0.01 0.01 0.02 0.02 0.00 0.00
Long-Term Debt to Equity
0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.50 -0.44 -0.48 -0.53 -0.52 -0.48 -0.52 -0.51 -0.47 -0.41 -0.36
Leverage Ratio
2.81 2.99 3.14 3.04 3.09 3.19 3.36 3.42 3.87 3.84 3.90
Compound Leverage Factor
2.76 3.00 3.15 3.27 2.86 3.08 3.39 3.41 3.99 3.81 3.89
Debt to Total Capital
6.49% 3.79% 1.90% 1.97% 2.21% 1.23% 1.22% 1.52% 2.15% 0.00% 0.00%
Short-Term Debt to Total Capital
4.40% 2.78% 0.99% 1.01% 1.13% 1.23% 1.22% 1.52% 2.15% 0.00% 0.00%
Long-Term Debt to Total Capital
2.08% 1.01% 0.91% 0.96% 1.08% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
93.51% 96.21% 98.10% 98.03% 97.79% 98.77% 98.79% 98.48% 97.85% 100.00% 100.00%
Debt to EBITDA
0.14 0.08 0.04 0.04 0.04 0.03 0.04 0.06 0.00 0.00 0.00
Net Debt to EBITDA
-1.00 -0.89 -1.04 -1.25 -1.00 -1.15 -1.61 -1.19 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.04 0.02 0.02 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.28 0.15 0.07 0.08 0.09 0.08 0.29 -0.87 0.00 0.00 0.00
Net Debt to NOPAT
-2.09 -1.83 -2.01 -2.63 -2.20 -3.16 -10.70 17.47 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.09 0.04 0.03 0.04 0.05 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
3.87 3.99 3.75 3.73 3.68 3.11 2.64 2.38 0.00 0.00 2.78
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.88 0.88 0.99 0.97 0.90 0.84 0.82 0.73 0.63 0.66 0.74
Quick Ratio
0.71 0.71 0.83 0.80 0.70 0.63 0.64 0.52 0.42 0.44 0.54
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
13 11 24 15 0.04 4.20 4.38 -11 7.20 4.83 4.08
Operating Cash Flow to CapEx
1,983.54% 906.10% 2,032.71% 1,417.33% -107.54% 352.05% 236.45% 5.67% 0.00% 97.23% 282.54%
Free Cash Flow to Firm to Interest Expense
39.49 44.73 116.38 83.17 0.29 31.15 45.63 -114.70 78.31 89.47 59.19
Operating Cash Flow to Interest Expense
38.95 33.09 107.74 79.47 -8.78 46.39 103.52 1.03 0.00 20.83 59.58
Operating Cash Flow Less CapEx to Interest Expense
36.98 29.44 102.44 73.86 -16.94 33.21 59.74 -17.15 0.00 -0.59 38.49
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.22 1.28 1.13 1.26 1.29 1.27 1.06 1.14 0.00 0.00 1.13
Accounts Receivable Turnover
5.03 4.85 3.42 4.75 5.18 5.08 3.46 4.35 0.00 0.00 3.84
Inventory Turnover
17.34 14.41 16.11 16.72 15.87 14.80 13.85 13.75 0.00 0.00 11.94
Fixed Asset Turnover
30.08 30.67 30.60 31.55 31.34 30.27 23.16 23.54 0.00 0.00 19.52
Accounts Payable Turnover
8.19 10.00 9.21 11.42 9.06 10.38 7.63 10.93 0.00 0.00 8.82
Days Sales Outstanding (DSO)
72.50 75.26 106.70 76.87 70.42 71.88 105.52 83.97 0.00 0.00 95.06
Days Inventory Outstanding (DIO)
21.04 25.32 22.66 21.83 22.99 24.66 26.35 26.54 0.00 0.00 30.57
Days Payable Outstanding (DPO)
44.54 36.51 39.62 31.95 40.30 35.18 47.83 33.40 0.00 0.00 41.37
Cash Conversion Cycle (CCC)
49.00 64.07 89.74 66.75 53.12 61.37 84.04 77.10 0.00 0.00 84.26
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
35 38 36 29 34 33 36 37 25 31 39
Invested Capital Turnover
6.83 6.84 6.85 8.04 8.34 7.87 7.41 7.90 0.00 0.00 6.96
Increase / (Decrease) in Invested Capital
-12 -5.34 -12 -14 -1.06 -5.75 -0.05 8.34 -8.60 -1.72 3.05
Enterprise Value (EV)
471 457 480 428 383 271 216 174 138 255 217
Market Capitalization
507 491 527 480 422 304 247 191 150 267 230
Book Value per Share
$5.33 $5.44 $6.35 $6.12 $5.50 $5.05 $5.29 $4.44 $3.29 $3.81 $4.55
Tangible Book Value per Share
$0.09 $0.16 $1.08 $0.93 $0.40 ($0.10) $0.09 ($0.91) ($2.22) ($1.79) ($0.96)
Total Capital
76 75 85 82 74 66 68 55 39 43 51
Total Debt
4.91 2.85 1.61 1.62 1.64 0.82 0.82 0.83 0.84 0.00 0.00
Total Long-Term Debt
1.58 0.76 0.78 0.79 0.80 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-36 -34 -47 -52 -39 -33 -31 -17 -13 -12 -13
Capital Expenditures (CapEx)
0.64 0.90 1.08 1.00 1.27 1.78 4.20 1.73 0.00 1.16 1.46
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-54 -51 -50 -57 -53 -54 -59 -56 -70 -60 -52
Debt-free Net Working Capital (DFNWC)
-13 -14 -1.37 -3.92 -12 -20 -27 -39 -56 -48 -39
Net Working Capital (NWC)
-16 -17 -2.20 -4.75 -13 -21 -28 -40 -57 -48 -39
Net Nonoperating Expense (NNE)
0.02 -0.01 -0.04 -0.08 0.06 -0.13 -0.04 0.73 0.58 0.02 0.02
Net Nonoperating Obligations (NNO)
-36 -34 -47 -52 -39 -33 -31 -17 -13 -12 -12
Total Depreciation and Amortization (D&A)
3.00 3.08 2.95 3.24 3.38 3.31 3.57 3.22 1.81 3.55 3.59
Debt-free, Cash-free Net Working Capital to Revenue
-19.20% -18.16% -17.42% -19.87% -18.38% -19.36% -21.98% -21.53% 0.00% 0.00% -19.95%
Debt-free Net Working Capital to Revenue
-4.55% -5.15% -0.48% -1.36% -4.26% -7.32% -10.11% -14.84% 0.00% 0.00% -14.86%
Net Working Capital to Revenue
-5.74% -5.89% -0.77% -1.65% -4.55% -7.61% -10.42% -15.15% 0.00% 0.00% -14.86%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.07 $0.43 $0.91 $0.09 ($0.08) ($0.11) $0.34 ($0.27) ($0.17) $0.27 $0.60
Adjusted Weighted Average Basic Shares Outstanding
13.26M 13.16M 13.17M 13.09M 13.10M 12.89M 12.93M 12.21M 11.42M 11.26M 11.55M
Adjusted Diluted Earnings per Share
$0.06 $0.43 $0.89 $0.09 ($0.08) ($0.11) $0.34 ($0.27) ($0.17) $0.27 $0.59
Adjusted Weighted Average Diluted Shares Outstanding
13.48M 13.38M 13.47M 13.27M 13.10M 12.89M 13.05M 12.21M 11.42M 11.45M 11.73M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
13.27M 13.09M 13.18M 13.20M 12.99M 12.64M 12.16M 11.55M 11.27M 11.29M 11.34M
Normalized Net Operating Profit after Tax (NOPAT)
2.53 6.19 12 2.57 -1.02 1.78 4.33 -0.14 -0.34 3.62 8.03
Normalized NOPAT Margin
4.12% 8.43% 14.16% 3.73% -1.71% 2.64% 6.08% -0.23% -0.57% 5.34% 11.47%
Pre Tax Income Margin
2.31% 11.40% 21.39% 2.30% -2.26% -3.17% 11.17% -5.67% -3.46% 6.14% 12.28%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4.40 33.78 88.32 8.29 -9.33 -16.32 82.16 -38.43 -21.73 77.70 124.90
NOPAT to Interest Expense
2.72 23.10 58.69 6.17 -6.53 -11.42 45.15 -26.90 -15.21 57.54 103.32
EBIT Less CapEx to Interest Expense
2.43 30.13 83.01 2.68 -17.49 -29.50 38.38 -56.61 0.00 56.28 103.81
NOPAT Less CapEx to Interest Expense
0.75 19.45 53.39 0.56 -14.69 -24.60 1.37 -45.08 0.00 36.12 82.23
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
288.32% 173.77% 131.39% 103.36% 151.81% 261.89% 859.65% -2,217.83% 0.00% 0.00% 571.40%

Financials Breakdown Chart

Key Financial Trends

Franklin Covey’s latest results show a recovery in quarterly profitability, but revenue remains below levels seen in prior years and operating cash flow is under pressure from working-capital needs. Figures below are in U.S. dollars; fiscal-year comparisons use the four reported quarters provided.

  • Q4 profitability improved year over year. Revenue was $70.0 million, down about 1.8% from Q4 2025, while operating income rose 9.3% to $8.6 million and net income attributable to shareholders increased to $7.1 million from $4.2 million. Diluted EPS advanced to $0.59 from $0.34.
  • Margins benefited from lower operating expenses. Q4 operating expenses fell to $43.7 million from $45.9 million a year earlier. Operating margin increased to about 12.3% from 11.1%, despite a modest decline in revenue.
  • Profitability improved for fiscal 2026 overall. Based on the quarterly figures provided, net income attributable to common shareholders totaled about $4.8 million, compared with $2.8 million in fiscal 2025. The company also returned to positive operating income for the year.
  • Revenue strengthened sequentially in the second half of fiscal 2026. Quarterly revenue rose from $59.6 million in Q2 to $67.8 million in Q3 and $70.0 million in Q4.
  • Reported debt was zero at Q3 2026. The balance sheet showed no short- or long-term debt at May 31, 2026, limiting interest-cost and debt-repayment pressures.
  • Deferred revenue and customer deposits are substantial. Together, these totaled about $113.0 million at Q3 2026. They reflect customer payments received ahead of delivery, so they can support cash flow but also represent services or products Franklin Covey still needs to provide.
  • Revenue has declined over the longer term. Fiscal-year revenue, calculated from the quarterly data, decreased from about $287.2 million in fiscal 2024 to $267.1 million in fiscal 2025 and $261.5 million in fiscal 2026. Q4 2026 revenue was also below the $84.1 million reported in Q4 2024.
  • Q4 operating cash flow fell year over year. Cash from operations was $4.1 million, down from $9.9 million in Q4 2025 and below Q4 net income of $7.1 million. A $7.8 million outflow from changes in operating assets and liabilities was a significant drag.
  • Liquidity measures weakened in the balance-sheet data. At Q3 2026, cash was $12.0 million and current assets were $91.8 million, compared with $33.7 million and $111.0 million, respectively, at Q3 2025. Current liabilities rose to $140.1 million from $132.3 million; the current ratio was about 0.65, although deferred revenue is a major component of those liabilities.
11/16/26 05:17 PM ETAI Generated. May Contain Errors.

Franklin Covey Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Franklin Covey's fiscal year ends in August. Their fiscal year 2026 ended on August 31, 2026.

Franklin Covey's net income appears to be on an upward trend, with a most recent value of $4.92 million in 2026, falling from $7.02 million in 2016. The previous period was $3.07 million in 2025. Find out what analysts predict for Franklin Covey in the coming months.

Franklin Covey's total operating income in 2026 was $7.16 million, based on the following breakdown:
  • Total Gross Profit: $196.03 million
  • Total Operating Expenses: $188.87 million

Over the last 10 years, Franklin Covey's total revenue changed from $400.11 million in 2016 to $261.46 million in 2026, a change of -34.7%.

In the past 13 quarters, Franklin Covey's cash and equivalents has ranged from $11.97 million in Q3 2026 to $55.12 million in Q2 2023, and is currently $11.97 million as of their latest financial filing in Q3 2026.

Franklin Covey had total debt of $0.00 at the end of 2026, a 100.0% decrease from 2025, and a 100.0% decrease since 2016.

Over the last 10 years, Franklin Covey's book value per share changed from 6.61 in 2016 to 4.55 in 2026, a change of -31.2%.



Financial statements for NYSE:FC last updated on 11/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners